U.S. Luxury Stock News

Lululemon athletica (NasdaqGS:LULU) has joined a $12 million funding round for Epoch Biodesign, a company working on enzyme based recycling of nylon 6,6 textiles. The investment aims to turn hard to recycle nylon and plastic waste into new materials that could be used in future lululemon products. This move supports lululemon’s broader circularity and sustainability goals, with potential implications for its raw material sourcing and waste footprint. Lululemon enters this partnership with...

Datavault AI stock: event driven snapshot Datavault AI (DVLT) has moved onto more investor watchlists after its recent rebrand from WiSA Technologies, Inc., sharpening market attention on its data management, AI agent, and wireless audio businesses. See our latest analysis for Datavault AI. The share price, now at $0.61, has retreated sharply in the short term, with a 7 day share price return of 34.39% and a year to date share price return of 39.60%. The 1 year total shareholder return of...

Fluor Corporation recently announced a limited notice to proceed with TeraWulf Inc. to begin master planning and pre-construction for a large-scale brownfield data center campus in North Central Kentucky, supported by up to 480 megawatts of grid-connected power and led from its Greenville, South Carolina execution hub. Alongside the recent opening of a new Bucharest office to support advanced nuclear projects, the TeraWulf data center mandate underscores how Fluor is positioning its...

In recent days, Golar LNG has been in focus after a missile attack on a major Qatari natural gas hub, which supplies around one-fifth of global LNG, disrupted regional supply and intensified concerns about energy security amid ongoing Middle East tensions. This disruption highlights how concentrated LNG infrastructure can quickly become a pressure point for producers, charterers, and floating LNG operators like Golar across global supply chains. We’ll now explore how this disruption at a key...

If you are wondering whether Astec Industries is still reasonably priced after its recent run, the stock's current valuation story is worth a closer look. The share price sits at US$54.87 after a 3.9% gain over the last 7 days, a 5.2% decline over 30 days, and returns of 22.9% year to date and 52.0% over 1 year, with a 3 year return of 41.6% and a 5 year return of a 22.9% decline. Recent coverage around Astec Industries has focused on its position within the capital goods space and how...

Moody's downgrade and monetization gains put KKR in focus KKR (KKR) is back in the spotlight after Moody's cut the rating on its FS KKR private credit fund to junk, while the firm separately reported more than US$700 million in monetization income this quarter. See our latest analysis for KKR. Despite the Moody's downgrade and monetization update, KKR's share price has come under pressure, with a 90 day share price return of a 32.02% decline and a year-to-date share price return of a 31.02%...

The Trump administration previously announced a voluntary investment consortium targeting up to US$4.00 trillion for semiconductor, energy, and critical minerals supply chains, with an initial US$250.00 million government contribution to support AI and chipmaking capabilities across the U.S. and allied nations. This initiative highlights how policy-driven capital could reinforce the ecosystem around materials suppliers like Entegris, which enable advanced semiconductor manufacturing. We’ll...

In recent days, Medtronic plc received U.S. FDA approval to expand use of its OmniaSecure defibrillation lead to the left bundle branch area and also entered a distribution agreement with Merit Medical Systems to offer the FDA-cleared ViaVerte basivertebral nerve ablation system for minimally invasive outpatient back pain treatment later this year. Together, these moves highlight Medtronic’s push to broaden its cardiac and pain therapy portfolios with specialized devices that could deepen...

Why Liberty Live Holdings is on investors’ radar Liberty Live Holdings (LLYV.K) has drawn attention after recent share price moves, with the stock showing mixed short term performance and a stronger total return over the past year. See our latest analysis for Liberty Live Holdings. The recent 1-day share price return of 1.47% takes Liberty Live Holdings to $94.99, while a 90-day share price return of 12.31% and 1-year total shareholder return of 37.37% indicate momentum building over the...

EnerSys (ENS) is reshaping its manufacturing footprint after announcing plans to close its legacy lead-acid battery plant in Tijuana, Mexico, and concentrate production at its TPPL facility in Springfield, Missouri. See our latest analysis for EnerSys. The restructuring news has arrived after a period of strong momentum, with the share price at US$177.42 and a 90-day share price return of 18.46%. The 1-year total shareholder return sits at 85.59%, pointing to investors reassessing both growth...

If you are wondering whether Doximity at around US$24.18 still reflects its underlying worth, the recent share performance gives you plenty to think about. The stock has been choppy, with a 2.5% decline over the last 7 days, a 1.8% gain over the last 30 days, and much steeper moves over longer periods, including a 44.1% decline year to date and a 60.7% decline over the last year. Against this backdrop, recent coverage has focused on how investors are reassessing digital health platforms and...

In March 2026, Zai Lab announced that three internally-developed oncology candidates, zocilurtatug pelitecan (zoci), ZL-6201, and ZL-1222, were presented across four poster sessions at the American Association for Cancer Research Annual Meeting 2026 in San Diego, highlighting progress in small cell lung cancer, sarcoma, and immuno-oncology programs. The company also outlined plans for three registration-enabling studies for zoci by the end of 2026, signaling its intent to position this...

Earlier this year, Corcept Therapeutics announced that the FDA approved Lifyorli (relacorilant) plus nab-paclitaxel for adults with previously treated platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer, based on the ROSELLA trial’s dual primary endpoint success in progression-free and overall survival. This approval introduces the first selective glucocorticoid receptor antagonist in oncology care, highlighting cortisol signaling as a new treatment pathway in...

If you are wondering whether ADMA Biologics at around US$9.63 still offers value, or if most of the opportunity has already played out, this article breaks down what the current price might be implying. The stock has seen sharp moves recently, with a 35.2% decline over the last week, a 40.9% decline over the last month, a 46.1% decline year to date, and a 51.1% decline over the last year, even after a very large 3 year return and a 7x 5 year return. Recent coverage has focused on these...

Vail Resorts, Inc. recently outlined a multi-year plan to roll My Epic Gear features into its traditional rental outlets, adding premium equipment choices, digital booking, and flexible pick-up or delivery options across its resort network. By turning rentals into a personalized, app-driven service with specific model selection and archived gear preferences, Vail Resorts is effectively treating equipment as a repeatable, data-informed experience rather than a one-off transaction. Next, we’ll...

Earlier this week, sentiment toward Take-Two Interactive softened after major competitor Epic Games announced over 1,000 job cuts tied to lower Fortnite engagement and unsustainable spending, stoking worries about the broader video game market. At the same time, Take-Two’s inclusion as a top holding in JPMorgan’s actively managed U.S. Tech Leaders ETF highlights how some fund managers still view the company as an important player at the intersection of gaming and technology, including...

What recent returns say about Leggett & Platt (LEG) Leggett & Platt (LEG) has drawn fresh attention after a mixed stretch of performance, with a 0.4% decline over the past day, a 2.5% gain over the past week, and weaker month and past 3 months returns. In this context, investors are weighing how the current US$10.10 share price and the company’s value score of 5 line up with its recent revenue and net income figures as well as its longer term track record. See our latest analysis for Leggett...

If you are wondering whether Becton Dickinson's current share price reflects its true worth, you are not alone. Many investors are asking the same question right now. The stock last closed at US$158.27, with returns of 0.1% over 7 days, a 14.1% decline over 30 days, an 18.8% decline year to date, and a 9.6% decline over the past year, which may be changing how investors think about its risk and potential. Recent headlines around Becton Dickinson have kept attention on how the company is...

Halozyme Therapeutics, Inc. recently appointed David Ramsay as Interim Chief Financial Officer, effective March 23, 2026, tasking him with overseeing all financial operations while the company continues its search for a permanent CFO. Ramsay’s long history with Halozyme and deep capital markets experience may offer continuity and financial discipline at a time when the company is expanding its ENHANZE and related partnerships. Next, we’ll examine how Ramsay’s return as interim CFO could...

Signet Jewelers (NYSE:SIG) approved an almost 10% increase to its quarterly dividend, marking a fifth consecutive year of higher shareholder payouts. The company also recently completed another tranche of its ongoing share repurchase program. These twin capital return actions arrive at a time when other coverage of NYSE:SIG has centered on earnings results and valuation. Signet Jewelers, the owner of jewelry retail banners such as Kay, Zales, and Jared, sits at the intersection of...

Earlier this month, UiPath unveiled a wave of new agentic AI offerings for finance, retail, manufacturing, and financial services, while expanding CTO Raghu Malpani’s remit to Chief Product and Technology Officer and filing a US$356.70 million shelf registration tied to employee stock plans. Together, these releases and leadership changes highlight UiPath’s push to become an AI orchestration layer for complex enterprise workflows, embedding domain-specific agents across core operational...

M-tron Industries (MPTI) closed FY 2025 with fourth quarter revenue of US$14.2 million and basic EPS of US$1.16, alongside trailing twelve month revenue of US$54.4 million and EPS of US$2.94 that frame the latest print in a broader earnings context. Over the past six reported quarters, the company has seen quarterly revenue range from US$12.8 million to US$14.2 million and basic EPS move between US$0.55 and US$1.16, giving you a clear view of how the top line and EPS have tracked into this...

DXC Technology (DXC) has just earned a spot on Fortune's America's Most Innovative Companies list, reflecting its recent AI focused launches. Investors are weighing this recognition against ongoing concerns about sales trends and capital allocation. See our latest analysis for DXC Technology. DXC's recent recognition for its AI efforts comes after a mixed stretch for shareholders, with a 1-day share price return of 3.36% and 7-day share price return of 3.00% contrasting with a 1-year total...

Enterprise Products Partners (EPD) is back in the spotlight after Co CEO and Director Jim Teague presented at the World Chemical Forum 2026, alongside fresh bullish commentary from Jim Cramer on its midstream role. See our latest analysis for Enterprise Products Partners. The recent World Chemical Forum appearance and positive TV commentary come as Enterprise Products Partners records a 21.3% year to date share price return and a 23.4% 1 year total shareholder return, pointing to firm...